{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:05:42Z","timestamp":1780106742478,"version":"3.54.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To compare post-epinephrine vasopressin administration versus epinephrine and time to return of spontaneous circulation (ROSC) during pediatric in-hospital cardiac arrest (IHCA), and explore vasopressin\u2019s physiologic effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, retrospective cohort study (2017\u20132023) compared vasopressin patients who received \u22651 dose of preceding epinephrine and matched epinephrine-only patients based on age, illness category, and preceding epinephrine dosing. Time to ROSC was analyzed using Cox regression. Vasopressor response was defined as \u22655\u2009mmHg increase in diastolic blood pressure (DBP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty-one matched pairs were analyzed. Median CPR duration was 36.5 [IQR 23, 48] minutes; median time to dose was 14.5 [10.8, 19] minutes. ROSC occurred in 10\/41 (24%) vasopressin and 15\/41 (36%) epinephrine patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.34) with no difference in time to ROSC (aHR 0.73 [95% CI: 0.31\u20131.7]). Vasopressor response occurred in 4\/12 (33%) vasopressin and 1\/7 (14%) epinephrine patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.60). Regression discontinuity analysis demonstrated a change in DBP of +2.3\u2009mmHg after vasopressin (95% CI: \u221211.4, 16.0) and \u22125.67\u2009mmHg after epinephrine (\u201315.13, 3.80).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No significant differences were found in time to ROSC or DBP increase between vasopressin and epinephrine given late during CPR. A subset of vasopressin responders suggests further research on intra-arrest DBP response to vasopressin is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The use of intra-arrest vasopressin is an understudied topic in pediatric cardiac arrest.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>This study presents a unique comparison of ongoing epinephrine to vasopressin administration, using dose matching to address the limitations of our current vasopressin use.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>We present a novel analysis of physiologic response to vasopressin using the change in diastolic blood pressure.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04374-6","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T11:02:10Z","timestamp":1759575730000},"page":"1872-1879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of vasopressin to epinephrine during pediatric in-hospital cardiac arrest: survival and physiologic responsiveness"],"prefix":"10.1038","volume":"99","author":[{"given":"Morgann","family":"Loaec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Keim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha F.","family":"Kienzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"O\u2019Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay N.","family":"Shepard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samridhi","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellimarie","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Kilbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Topjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan W.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"4374_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.005580","volume":"12","author":"MJ Holmberg","year":"2019","unstructured":"Holmberg, M. J. et al. Annual incidence of adult and pediatric in-hospital cardiac arrest in the United States. Circ. Cardiovasc. Qual. Outcomes 12, e005580 (2019).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"4374_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/CCM.0000000000005715","volume":"51","author":"RA Berg","year":"2023","unstructured":"Berg, R. A. et al. Diastolic blood pressure threshold during pediatric cardiopulmonary resuscitation and survival outcomes: a multicenter validation study. Crit. Care Med. 51, 91\u2013102 (2023).","journal-title":"Crit. Care Med."},{"key":"4374_CR3","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.117.032270","volume":"137","author":"RA Berg","year":"2018","unstructured":"Berg, R. A. et al. Association between diastolic blood pressure during pediatric in-hospital cardiopulmonary resuscitation and survival. Circulation 137, 1784\u20131795 (2018).","journal-title":"Circulation"},{"key":"4374_CR4","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/jama.1990.03440080084029","volume":"263","author":"NA Paradis","year":"1990","unstructured":"Paradis, N. A. et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 263, 1106\u20131113 (1990).","journal-title":"JAMA"},{"key":"4374_CR5","doi-asserted-by":"publisher","first-page":"S469","DOI":"10.1161\/CIR.0000000000000901","volume":"142","author":"AA Topjian","year":"2020","unstructured":"Topjian, A. A. et al. Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 142, S469\u2013S523 (2020).","journal-title":"Circulation"},{"key":"4374_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04399-5","volume":"27","author":"RW Morgan","year":"2023","unstructured":"Morgan, R. W. et al. The physiologic response to epinephrine and pediatric cardiopulmonary resuscitation outcomes. Crit. Care 27, 105 (2023).","journal-title":"Crit. Care"},{"key":"4374_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.resuscitation.2019.04.008","volume":"139","author":"MJ Holmberg","year":"2019","unstructured":"Holmberg, M. J. et al. Vasopressors during adult cardiac arrest: a systematic review and meta-analysis. Resuscitation 139, 106\u2013121 (2019).","journal-title":"Resuscitation"},{"key":"4374_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/01.CIR.91.1.215","volume":"91","author":"KH Lindner","year":"1995","unstructured":"Lindner, K. H. et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 91, 215\u2013221 (1995).","journal-title":"Circulation"},{"key":"4374_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/pr.2014.38","volume":"75","author":"PJ McNamara","year":"2014","unstructured":"McNamara, P. J. et al. Vasopressin improves survival compared with epinephrine in a neonatal piglet model of asphyxial cardiac arrest. Pediatr. Res. 75, 738\u2013748 (2014).","journal-title":"Pediatr. Res."},{"key":"4374_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.resplu.2020.100050","volume":"4","author":"JC Slovis","year":"2020","unstructured":"Slovis, J. C. et al. The physiologic response to rescue therapy with vasopressin versus epinephrine during experimental pediatric cardiac arrest. Resusc. Plus 4, 100050 (2020).","journal-title":"Resusc. Plus"},{"key":"4374_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0036-1583282","volume":"5","author":"K Choong","year":"2016","unstructured":"Choong, K. Vasopressin in pediatric critical care. J. Pediatr. Intensive Care 5, 182\u2013188 (2016).","journal-title":"J. Pediatr. Intensive Care"},{"key":"4374_CR12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1553-2712.1997.tb03813.x","volume":"4","author":"DC Morris","year":"1997","unstructured":"Morris, D. C. et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad. Emerg. Med. 4, 878\u2013883 (1997).","journal-title":"Acad. Emerg. Med."},{"key":"4374_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/cc8224","volume":"15","author":"JA Russell","year":"2011","unstructured":"Russell, J. A. Bench-to-bedside review: vasopressin in the management of septic shock. Crit. Care 15, 226 (2011).","journal-title":"Crit. Care"},{"key":"4374_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/PCC.0b013e31822f1569","volume":"13","author":"TG Carroll","year":"2012","unstructured":"Carroll, T. G., Dimas, V. V. & Raymond, T. T. Vasopressin rescue for in-pediatric intensive care unit cardiopulmonary arrest refractory to initial epinephrine dosing: a prospective feasibility pilot trial. Pediatr. Crit. Care Med 13, 265\u2013272 (2012).","journal-title":"Pediatr. Crit. Care Med"},{"key":"4374_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/PCC.0b013e31819a36f2","volume":"10","author":"JM Duncan","year":"2009","unstructured":"Duncan, J. M. et al. Vasopressin for in-hospital pediatric cardiac arrest: results from the American Heart Association National Registry of Cardiopulmonary Resuscitation. Pediatr. Crit. Care Med. 10, 191\u2013195 (2009).","journal-title":"Pediatr. Crit. Care Med."},{"key":"4374_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s13312-021-2256-9","volume":"58","author":"A Sheriff","year":"2021","unstructured":"Sheriff, A. et al. Epinephrine plus vasopressin vs epinephrine plus placebo in pediatric intensive care unit cardiopulmonary resuscitation: a randomized double blind controlled clinical trial. Indian Pediatr. 58, 624\u2013630 (2021).","journal-title":"Indian Pediatr."},{"key":"4374_CR17","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.CIR.99.10.1379","volume":"99","author":"V Wenzel","year":"1999","unstructured":"Wenzel, V. et al. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 99, 1379\u20131384 (1999).","journal-title":"Circulation"},{"key":"4374_CR18","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1161\/CIR.0000000000001179","volume":"148","author":"KM Berg","year":"2023","unstructured":"Berg, K. M. et al. 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: summary from the basic life support; advanced life support; pediatric life support; neonatal life support; education, implementation, and teams; and first aid task forces. Circulation 148, e187\u2013e280 (2023).","journal-title":"Circulation"},{"key":"4374_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jama.2015.9678","volume":"314","author":"LW Andersen","year":"2015","unstructured":"Andersen, L. W. et al. Time to epinephrine and survival after pediatric in-hospital cardiac arrest. JAMA 314, 802\u2013810 (2015).","journal-title":"JAMA"},{"key":"4374_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.resuscitation.2017.05.023","volume":"117","author":"DB Hoyme","year":"2017","unstructured":"Hoyme, D. B. et al. Epinephrine dosing interval and survival outcomes during pediatric in-hospital cardiac arrest. Resuscitation 117, 18\u201323 (2017).","journal-title":"Resuscitation"},{"key":"4374_CR21","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1164\/rccm.202012-4437OC","volume":"204","author":"MF Kienzle","year":"2021","unstructured":"Kienzle, M. F. et al. The effect of epinephrine dosing intervals on outcomes from pediatric in-hospital cardiac arrest. Am. J. Respir. Crit. Care Med. 204, 977\u2013985 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"4374_CR22","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1097\/CCM.0000000000006334","volume":"52","author":"MF Kienzle","year":"2024","unstructured":"Kienzle, M. F. et al. Epinephrine dosing intervals are associated with pediatric in-hospital cardiac arrest outcomes: a multicenter study. Crit. Care Med. 52, 1344\u20131355 (2024).","journal-title":"Crit. Care Med."},{"key":"4374_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.resuscitation.2021.01.015","volume":"160","author":"S Ohshimo","year":"2021","unstructured":"Ohshimo, S. et al. Pediatric timing of epinephrine doses: a systematic review. Resuscitation 160, 106\u2013117 (2021).","journal-title":"Resuscitation"},{"key":"4374_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0300-9572(01)00470-1","volume":"52","author":"K Mann","year":"2002","unstructured":"Mann, K., Berg, R. A. & Nadkarni, V. Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: a case series. Resuscitation 52, 149\u2013156 (2002).","journal-title":"Resuscitation"},{"key":"4374_CR25","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jama.2022.1738","volume":"327","author":"R Icu","year":"2022","unstructured":"Icu, R. et al. Effect of physiologic point-of-care cardiopulmonary resuscitation training on survival with favorable neurologic outcome in cardiac arrest in pediatric ICUs: a randomized clinical trial. JAMA 327, 934\u2013945 (2022).","journal-title":"JAMA"},{"key":"4374_CR26","doi-asserted-by":"publisher","first-page":"e065061","DOI":"10.1136\/bmjopen-2022-065061","volume":"13","author":"W Yan","year":"2023","unstructured":"Yan, W. et al. Therapeutic effects of vasopressin on cardiac arrest: a systematic review and meta-analysis. BMJ Open 13, e065061 (2023).","journal-title":"BMJ Open"},{"key":"4374_CR27","doi-asserted-by":"publisher","first-page":"e2424670","DOI":"10.1001\/jamanetworkopen.2024.24670","volume":"7","author":"A O\u2019Halloran","year":"2024","unstructured":"O\u2019Halloran, A. et al. Characteristics of pediatric in-hospital cardiac arrests and resuscitation duration. JAMA Netw. Open 7, e2424670 (2024).","journal-title":"JAMA Netw. Open"},{"key":"4374_CR28","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.119.041667","volume":"140","author":"MJ Holmberg","year":"2019","unstructured":"Holmberg, M. J. et al. Trends in survival after pediatric in-hospital cardiac arrest in the United States. Circulation 140, 1398\u20131408 (2019).","journal-title":"Circulation"},{"key":"4374_CR29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamapediatrics.2020.5039","volume":"175","author":"RW Morgan","year":"2021","unstructured":"Morgan, R. W. et al. Pediatric in-hospital cardiac arrest and cardiopulmonary resuscitation in the United States: a review. JAMA Pediatr. 175, 293\u2013302 (2021).","journal-title":"JAMA Pediatr."},{"key":"4374_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04962-8","volume":"28","author":"SD Mentzelopoulos","year":"2024","unstructured":"Mentzelopoulos, S. D. & Chalkias, A. A critical reappraisal of vasopressin and steroids in in-hospital cardiac arrest. Crit. Care 28, 191 (2024).","journal-title":"Crit. Care"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04374-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04374-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:01:53Z","timestamp":1780102913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04374-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4374"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04374-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}